These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11927381)

  • 1. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene.
    Yokoi H; Nagasaki H; Tachikawa K; Arima H; Murase T; Miura Y; Hirabayashi M; Oiso Y
    J Endocrinol; 2002 Apr; 173(1):23-33. PubMed ID: 11927381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of vasopressin in the rat transgenic for the metallothionein-vasopressin fusion gene.
    Nagasaki H; Yokoi H; Arima H; Hirabayashi M; Ishizaki S; Tachikawa K; Murase T; Miura Y; Oiso Y
    J Endocrinol; 2002 Apr; 173(1):35-44. PubMed ID: 11927382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration.
    Tian Y; Serino R; Verbalis JG
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F797-805. PubMed ID: 15213068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of oxytocin affects vasopressin V2 receptor and aquaporin-2 gene expression in the rat.
    Terashima Y; Kondo K; Oiso Y
    Life Sci; 1999; 64(16):1447-53. PubMed ID: 10321724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat.
    Tachikawa K; Yokoi H; Nagasaki H; Arima H; Murase T; Sugimura Y; Miura Y; Hirabayashi M; Oiso Y
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1161-6. PubMed ID: 12915399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.
    Gattone VH; Maser RL; Tian C; Rosenberg JM; Branden MG
    Dev Genet; 1999; 24(3-4):309-18. PubMed ID: 10322639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
    Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
    Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
    Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of acute elevation of plasma AVP level on rat vasopressin V2 receptor and aquaporin-2 mRNA expression.
    Terashima Y; Kondo K; Mizuno Y; Iwasaki Y; Oiso Y
    J Mol Endocrinol; 1998 Apr; 20(2):281-5. PubMed ID: 9584842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV; Bichet DG; Nielsen S; Nørgaard JP
    Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic AVP deficiency abolishes cold-induced diuresis but does not attenuate cold-induced hypertension.
    Sun Z
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1472-7. PubMed ID: 16396942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney.
    Hassan A; Tian Y; Zheng W; Ji H; Sandberg K; Verbalis JG
    Physiol Genomics; 2005 May; 21(3):382-8. PubMed ID: 15784697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inner Ear Arginine Vasopressin-Vasopressin Receptor 2-Aquaporin 2 Signaling Pathway Is Involved in the Induction of Motion Sickness.
    Xu LH; Yang Y; Liu HX; Xiao SF; Qiu WX; Wang JX; Zhao CC; Gui YH; Liu GZ; Peng B; Li X; Wang GH; Zhou X; Jiang ZL
    J Pharmacol Exp Ther; 2020 May; 373(2):248-260. PubMed ID: 32165443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats.
    Fujio T; Fujihara H; Shibata M; Yamada S; Onaka T; Tanaka K; Morita H; Dayanithi G; Kawata M; Murphy D; Ueta Y
    J Neuroendocrinol; 2006 Oct; 18(10):776-85. PubMed ID: 16965296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
    Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
    Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation.
    Memetimin H; Izumi Y; Nakayama Y; Kohda Y; Inoue H; Nonoguchi H; Tomita K
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F620-8. PubMed ID: 19587140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise.
    Hew-Butler T; Hummel J; Rider BC; Verbalis JG
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R366-75. PubMed ID: 24944242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.
    Burrell LM; Phillips PA; Risvanis J; Chan RK; Aldred KL; Johnston CI
    Am J Physiol; 1998 Jul; 275(1):H176-82. PubMed ID: 9688911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine vasopressin mediates the chloroquine induced increase in renal sodium excretion.
    Musabayane CT; Windle RJ; Forsling ML; Balment RJ
    Trop Med Int Health; 1996 Aug; 1(4):542-50. PubMed ID: 8765464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.